During the past decade, Vanderbilt-Ingram Cancer Center at Franklin conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vanderbilt-Ingram Cancer Center at Franklin" #1 sponsor was "Vanderbilt-Ingram Cancer Center" with 30 trials, followed by "Vanderbilt University" with 12 trials sponsored, "Vanderbilt University Medical Center" with 10 trials sponsored, "NRG Oncology" with 2 trials sponsored and "National Cancer Institute (NCI)" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vanderbilt-Ingram Cancer Center at Franklin" #1 collaborator was "National Cancer Institute (NCI)" with 55 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Vanderbilt-Ingram Cancer Center at Franklin" are "Head and Neck Cancer" (16 trials), "Breast Cancer" (10 trials), "Lung Cancer" (8 trials), "Colorectal Cancer" (7 trials) and "Lymphoma" (5 trials). Many other conditions were trialed in "Vanderbilt-Ingram Cancer Center at Franklin" in a lesser frequency.

Most popular intervention types in "Vanderbilt-Ingram Cancer Center at Franklin" are "Other" (38 trials), "Procedure" (21 trials), "Drug" (20 trials), "Genetic" (15 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "laboratory biomarker analysis" (15 trials), "medical chart review" (10 trials), "gene expression analysis" (8 trials), "quality-of-life assessment" (7 trials) and "questionnaire administration" (7 trials). Other intervention names were less common.

The vast majority of trials in "Vanderbilt-Ingram Cancer Center at Franklin" are 52 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Vanderbilt-Ingram Cancer Center at Franklin". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Vanderbilt-Ingram Cancer Center at Franklin, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Vanderbilt-Ingram Cancer Center at Franklin, 8 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".